Effect of red wine polyphenol dietary supplementation on two phase II enzymes in liver of hyperhomocysteinemic mice

Food and Chemical Toxicology

Volumn 49, Issue 8, 2011, Pages 1764-1769

  Noll, Christophe ^a   Dairou, Julien ^a   Ripoll, Clémentine ^a   Paul, Jean Louis ^b,c   Dupret, Jean Marie ^a   Delabar, Jean Maurice ^a   Rodrigues Lima, Fernando ^a   Janel, Nathalie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Arylamine N acetyltransferase; Homocysteine; Liver; Mice; NAD(P)H:quinone oxidoreductase; Polyphenols

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE 1; ARYLAMINE ACETYLTRANSFERASE 2; HOMOCYSTEINE; MESSENGER RNA; PEROXYNITRITE; POLYPHENOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; HYPERHOMOCYSTEINEMIA; LIVER LEVEL; MOUSE; NONHUMAN; RED WINE;

ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; ARYLDIALKYLPHOSPHATASE; DIETARY SUPPLEMENTS; FEMALE; FLAVONOIDS; HYPERHOMOCYSTEINEMIA; LIVER; MALE; MICE; MICE, KNOCKOUT; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; PHENOLS; WINE;

MURINAE; MUS;

EID: 79958696362     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.04.024     Document Type: Article

References (32)

1. Atmane N., Dairou J., Paul A., Dupret J.M., Rodrigues-Lima F. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide. J. Biol. Chem. 2003, 278:35086-35092.
2. Bea F., Hudson F.N., Neff-Laford H., White C.C., Kavanagh T.J., Kreuzer J., Preusch M.R., Blessing E., Katus H.A., Rosenfeld M.E. Homocysteine stimulates antioxidant response element-mediated expression of glutamate-cysteine ligase in mouse macrophages. Atherosclerosis 2009, 203:105-111.
3. Benson A.M., Hunkeler M.J., Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcino-genesis and toxicity. Proc. Natl. Acad. Sci. USA 1980, 77:5216-5220.
4. Boukouvala S., Price N., Plant K.E., Sim E. Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice. Biochem. J. 2003, 375:593-602.
5. Dairou J., Atmane N., Dupret J.M., Rodrigues-Lima F. Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols. Biochem. Biophys. Res. Commun. 2003, 307:1059-1065.
6. Dairou J., Atmane N., Rodrigues-Lima F., Dupret J.M. Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study. J. Biol. Chem. 2004, 279:7708-7714.
7. Dairou J., Dupret J.M., Rodrigues-Lima F. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells. FEBS Lett. 2005, 579:4719-4723.
8. Ernster L. DT diaphorase. Methods Enzymol. 1967, 10:309-317.
9. Estrada-Rodgers L., Levy G.N., Weber W.W. Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells. Drug. Metab. Dispos. 1998, 26:502-505.
10. Fortin L.J., Genest J.Jr. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin. Biochem. 1995, 28:155-162.
11. Gouédard C., Barouki R., Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 2004, 24:5209-5222.
12. Grant D.M., Blum M., Beer M., Meyer U.A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 1991, 39:184-191.
13. Hamelet J., Demuth K., Delabar J.M., Janel N. Inhibition of extracellular signal-regulated kinase in liver of hyperhomocysteinemic mice. Arterioscler. Thromb. Vas. 2006, 26:e126-e127.
14. Hamelet J., Aït-Yahya-Graison E., Matulewicz E., Noll C., Badel-Chagnon A., Camproux A.C., Demuth K., Paul J.L., Delabar J.M., Janel N. Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice. Eur. J. Clin. Invest. 2007, 37:933-938.
15. Hernandez-Trujillo Y., Rodriguez-Esparragon F., Macias-Reyes A., Caballero-Hidalgo A., Rodriguez-Perez J.C. Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model. Cardiovasc. Diabetol. 2008, 7:1-15.
16. Kawamura A., Westwood I., Wakefield L., Long H., Zhang N., Walters K., Redfield C., Sim E. Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1. Biochem. Pharmacol. 2008, 75:1550-1560.
17. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J. Clin. Invest. 1996, 98:5-7.
18. Miller E.C., Miller J.A. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharmacol. Rev. 1966, 18:805-838.
19. Miller E.C., Miller J.A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981, 47:2327-2345.
20. Moradi H., Pahl M.V., Elahimehr R., Vaziri N.D. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease. Transl. Rev. 2009, 153:77-85.
21. Na H.K., Surh Y.J. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food. Chem. Toxicol. 2008, 46:1271-1278.
22. Noll C., Hamelet J., Matulewicz E., Paul J.L., Delabar J.M., Janel N. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice. J. Nutr. Biochem. 2009, 20:586-596.
23. Noll, C., Raaf, L., Planque, C., Benard, L., Secardin, L., Petit, E., Dairou, J., Paul, J.L., Samuel, J.L., Delcayre, C., Rodrigues-Lima, F., Janel, N., in press. Protection and reversal of hepatic fibrosis by red wine polyphenols in hyperhomocysteinemic mice. J. Nutr. Biochem.
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:2002-2007.
25. Ren C., Park S.K., Vokonas P.S., Sparrow D., Wilker E., Baccarelli A., Suh H.H., Tucker K.L., Wright R.O., Schwartz J. Air pollution and homocysteine: more evidence that oxidative stress-related genes modify effects of particulate air pollution. Epidemiology 2010, 21:198-206.
26. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 1999, 19:217-246.
27. Sim E., Lack N., Wang C.J., Long H., Westwood I., Fullam E., Kawamura A. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms. Toxicology 2008, 254:170-183.
28. Stanisławska-Sachadyn A., Jensen L.E., Kealey C., Woodside J.V., Young I.S., Scott J.M., Murray L., Boreham C.A., McNulty H., Strain J.J., Whitehead A.S. Association between the NAT1 1095C>A polymorphism and homocysteine concentration. Am. J. Med. Genet. A 2006, 140:2374-2377.
29. Wakefield L., Boukouvala S., Sim E. Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene-environment interaction in a polymorphic gene implicated in folate metabolism. Gene 2010, 452:16-21.
30. Watanabe M., Osada J., Aratani Y., Kluckman K., Reddick R., Malinow M.R., Maeda N. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 1995, 5:1585-1589.
31. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 1998, 15:1042-1050.
32. Zipper L.M., Mulcahy R.T. Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol. Sci. 2003, 73:124-134.